Raphael Pharmaceutical Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Raphael Pharmaceutical Inc. (RAPH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.00 million shares for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2024-03-28
- Raphael Pharmaceutical Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.00M shares, a 0.00% change from fiscal 2022.
- Raphael Pharmaceutical Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.00M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|
| 2023-12-31 | 1.00M shares 10-K · filed 2024-03-28 |
| 2022-12-31 | 1.00M shares 10-K/A · filed 2023-05-25 |